Literature DB >> 27079600

Topical timolol maleate 0.5% solution for the management of deep periocular infantile hemangiomas.

Sally L Painter1, Göran Darius Hildebrand2.   

Abstract

This retrospective, consecutive, clinical case series examined the use of topical timolol in the treatment of 5 children with deep, periocular infantile hemangiomas that caused astigmatism, change in head posture, or ptosis. All patients were treated with timolol maleate solution 0.5% twice daily until the lesions had regressed. All 5 children showed regression of the lesion and improvement in amblyogenic risk factors within 2 weeks. Crown
Copyright © 2016. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27079600     DOI: 10.1016/j.jaapos.2015.11.012

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  2 in total

1.  Early and Late Histological and Ultrastructural Findings in Resected Infantile Capillary Hemangiomas Following Treatment with Topical Beta-Blocker Timolol Maleate 0.5.

Authors:  Zuzana Sipkova; Kanmin Xue; Hardeep S Mudhar; Bart Wagner; Göran Darius Hildebrand
Journal:  Ocul Oncol Pathol       Date:  2017-08-23

2.  Role of topical beta blockers in regression of infantile capillary hemangioma.

Authors:  Murtaza Sameen Junejo; Maria Nazish Memon; Sajida Parveen Shaikh
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.